AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Anteris Technologies Global Corp.
Video analysis: AVR
All videosNo video analysis for this stock yet. Request one from our team.
News: AVR
Anteris Technologies appoints Brent Moen as chief financial officer
Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September...
BlackRock Inc. Acquires Shares of 5,771,213 Anteris Technologies Global Corp. $AVR
BlackRock Inc. bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,771,213 shares of the company's stock, valued at approximately $56,846,000. BlackRock Inc. owned approximately 5.93%
Anteris to Present at September Healthcare Investor Conferences
MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, is pleased to advise that Vice Chairman and Chief Executive Officer, Wayne Paterson, will be presenting at the Cantor Global Healthcare Conference, the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference. The details of each conference are as follows: Cantor Global Healthcare Conference Date: Wednesday, September 9, 2026 (US time) Format: Fireside chat with analyst, Gabie Ingoglia, and 1x1 meetings Time: 11:30AM (US EST) Room: Track 1 – Metropolitan Room Location: Waldorf Astoria Hotel, New York Wells Fargo Healthcare Conference Date: Thursday, September 10, 2026 (US time) Format: Fireside chat with analyst, Larry Biegelsen, and 1x1 meetings Time: 9:30AM (US EST) Room: Track 1 – Picasso 6 Location: Encore Boston Harbor Hotel, Boston Morgan Stanley Healthcare Conference Date: Monday, September 14, 2026 (US time) Format: Fireside chat with Morgan Stanley Healthcare Team Time: 9:15AM (US EST) Room: Soho Complex 7th Floor Location: Sheraton Times Square Hotel, New York About Anteris Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function.
ADAR1 Capital Management LLC Acquires New Position in Anteris Technologies Global Corp. $AVR
ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,145,096 shares of the company's stock, valued at approximately $30,979,000. Anteris Technologies
Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR
Assenagon Asset Management S.A. bought a new stake in Anteris Technologies Global Corp. (NASDAQ: AVR) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 644,668 shares of the company's stock, valued at approximately $6,350,000. Assenagon Asset Management S.A.
Anteris Technologies Announces Results for the Second Quarter of 2026
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026 Highlights Secured U.S. Medicare reimbursement eligibility for the global pivotal PARADIGM Trial under a Centers for Medicare & Medicaid Services (CMS) national coverage policy, enabling reimbursement for eligible procedures at U.S. sites.
Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 174,721 Shares
Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty Ltd sold 174,721 shares of the company's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10. Following the transaction, the insider directly owned 5,439,000 shares of
